Efficacy of GLP-1RA according to Type 2 Diabetes Phenotypes-A Monocentric Retrospective Study

被引：0
|
作者：
Caruso, Irene
Giordano, Fiorella
Di Gioia, Ludovico
Matichecchia, Immacolata I.
Cignarelli, Angelo
Sorice, Gian Pio
Perrini, Sebastio
Natalicchio, Annalisa
Laviola, Luigi
Giorgino, Francesco
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-783-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
783-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Glycaemic control and beta cell function in type 2 diabetes on SGLT2i and GLP-1RA combination therapy
    Martinez, R.
    Al-Jobory, H.
    Adams, J.
    Chavez-Velasquez, A.
    Triplitt, C.
    DeFronzo, R. A.
    Cersosimo, E.
    DIABETOLOGIA, 2017, 60 : S408 - S409
  • [22] Efficacy and safety of IDegLira (combination of insulin degludec plus liraglutide), in insulin-naive patients with type 2 diabetes uncontrolled on GLP-1 receptor agonist (GLP-1RA) therapy
    Linjawi, S.
    Bode, B. W.
    Chaykin, L. B.
    Courreges, J. -P.
    Handelsman, Y.
    Lehmann, L. M.
    Mishra, A.
    Simpson, R. W.
    DIABETOLOGIA, 2015, 58 : S401 - S402
  • [23] Efficacy and Safety of Finerenone in Patients with CKD and T2D by GLP-1RA Treatment
    Rossing, Peter
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Amod, Aslam
    Marre, Michel
    Joseph, Amer
    Lage, Andrea
    Scott, Charlie
    Bakris, George L.
    AMERICAN HEART JOURNAL, 2021, 242 : 160 - 160
  • [24] The Efficacy of Treatment Intensification by Quadruple Oral Therapy Compared to GLP-1RA Therapy in Poorly Controlled Type 2 Diabetes Mellitus Patients A Real-World Data Study
    Kim, Minyoung
    Kim, Hosu
    Kim, Kyong Young
    Kim, Soo Kyoung
    Jung, Junghwa
    Hahm, Jong Ryeal
    Jung, Jaehoon
    Baek, Jong Ha
    DIABETES & METABOLISM JOURNAL, 2023, 47 (01) : 135 - 139
  • [25] Efficacy and Safety of Finerenone in Patients with CKD and T2D by GLP-1RA Treatment
    Rossing, Peter
    Agarwal, Rajiv
    Anker, Stefan
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Amod, Aslam
    Marre, Michel
    Joseph, Amer
    Lage, Andrea Z.
    Scott, Charlie
    Bakris, George
    DIABETES, 2021, 70
  • [26] Comparative Safety and Effectiveness of GLP-1RA and SGLT2i Use in Adults with Type 2 Diabetes in US Clinical Practice
    Hoffman, Sarah R.
    Lanes, Stephan
    Quimbo, Tracey
    Papazian, Aanahit
    White, Jeff
    Fisher, Vicki
    Cziraky, Mark J.
    Crowley, Matthew J.
    Willey, Vincent
    DIABETES, 2024, 73
  • [27] Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care
    Bonora, Benedetta Maria
    Rigato, Mauro
    Frison, Vera
    D'Ambrosio, Michele
    Tadiotto, Federica
    Lapolla, Annunziata
    Simioni, Natalino
    Paccagnella, Agostino
    Avogaro, Angelo
    Fadini, Gian Paolo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 173
  • [28] Fixed-Ratio Combinations of Basal Insulin and GLP-1RA in the Management of Type 2 Diabetes Mellitus: Highlights from the Literature
    Lisco, Giuseppe
    De Tullio, Anna
    Guastamacchia, Edoardo
    Triggiani, Vincenzo
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (04) : 626 - 646
  • [29] Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial
    Rossing, Peter
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Amod, Aslam
    Marre, Michel
    Joseph, Amer
    Lage, Andrea
    Scott, Charlie
    Bakris, George L.
    DIABETES OBESITY & METABOLISM, 2022, 24 (01): : 125 - 134
  • [30] Real-World Adherence and Discontinuation of GLP-1 Receptor Agonist (GLP-1RA) Therapy in Type 2 Diabetes (T2D) Patients in the US
    Weiss, Tracey
    Iglay, Kristy
    Carr, Richard D.
    Mishra, Ajay Pratap
    Yang, Lingfeng
    Rajpathak, Swapnil
    DIABETES, 2019, 68
12345